AFT Pharmaceuticals Ltd (ASX:AFP)
A$ 2.55 -0.02 (-0.78%) Market Cap: 247.03 Mil Enterprise Value: 265.29 Mil PE Ratio: 18.46 PB Ratio: 3.31 GF Score: 88/100

Interim 2020 AFT Pharmaceuticals Ltd Earnings Call Transcript

Nov 20, 2019 / 09:00PM GMT
Release Date Price: A$2.68
Operator

Ladies and gentlemen, thank you for standing by and welcome to the AFT Pharmaceuticals half year results analyst briefing. (Operator Instructions)

With us today, we have Hartley Atkinson, CEO and Managing Director; and Malcolm Tubby, CFO. (Operator Instructions) Please be advised that this conference is being recorded.

I would now like to hand the conference over to your first speaker, Hartley Atkinson. Thank you. Please go ahead.

Hartley Atkinson
AFT Pharmaceuticals Limited - Founder, CEO, MD & Executive Director

Thank you very much. Welcome, everyone, to our half year investor presentation. So look, I'm assuming you've got the presentation. And what I'll do is I will go through the presentation, just to outline the highlights referring to the page numbers, and then we've got time for questions after that.

So we've got the cover page and then the disclaimer page on Page 2, so please be aware of that.

And then looking at Page 3, which is the half year highlights. Where we're currently at is we've increased the number

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot